Found 716 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
D
David Plager, MD
The purpose of this study is to evaluate the safety and effectiveness of an intraocular (IOL) lens called the ARTISAN? Aphakia Lens for the correction of aphakia.
F
Flora Hammond, MD
The purpose of the study is to see if buspirone is effective in treating irritability and aggression in people who have had a traumatic brain injury.
M
Michael Ferguson, MD
The purpose of this Phase II Study is to determine the response rate of NFI patients with plexiform neurofibromas treated with Cabozantinib therapy using MRI scans.
B
Brian Mullis, MD
The purpose of this study is to determine if there is a difference in outcomes between liberal transfusion and conservative transfusion.
J
James Croop, MD, PhD
This phase I/II trial studies the side effects and best dose of WEE1 inhibitor MK-1775 and irinotecan hydrochloride in treating younger patients with solid tumors that have come back or that have not responded to standard therapy. WEE1 inhibitor MK-1775 and irinotecan hydrochloride may stop the growth of tumor cells …
S
Sandeep Batra, MD
This partially randomized phase II trial studies how well brentuximab vedotin or crizotinib and combination chemotherapy works in treating patients with newly diagnosed stage II-IV anaplastic large cell lymphoma.
L
Linda DiMeglio, MD
The purpose of the recruitment database is to store information on people who might be eligible to participate in current or future diabetes research studies.
S
Sandeep Batra, MD
This randomized phase III clinical trial compares how well combination chemotherapy works when given with or without bortezomib in treating patients with newly diagnosed T-cell acute lymphoblastic leukemia or stage II-IV T-cell lymphoblastic lymphoma.
S
Sandeep Batra, MD
This randomized phase III trial compares how well blinatumomab works compared with standard combination chemotherapy in treating patients with B-cell acute lymphoblastic leukemia that has returned after a period of improvement (relapsed).
S
Sandeep Batra, MD
This randomized phase II trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing sarcoma that has spread to other parts of the body.
